McLeod Orthopaedics, part of Florence, S.C.-based McLeod Health, added Paul Weatherby, MD, to its staff.  Dr. Weatherby is an orthopedic surgeon specializing in foot and ankle procedures, according to ...

Nextremity Solutions LLC has obtained ISO 13485 certification and CE mark certification of the Nextra Hammertoe Correction System. “The company will now mobilize its resources to train orthopedic ...

ALPHARETTA, Ga.--(BUSINESS WIRE)--Cartiva, Inc., (the “Company”) a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and other musculoskeletal conditions, ...

HUNTLEY, Ill.--(BUSINESS WIRE)--Centric Medical, the Foot & Ankle division of Life Spine, Inc., which focuses on developing surgical implants for the treatment of distal extremity pathology announced ...

According to the latest research assessment of the Hammertoe Correction System Market by Report Ocean, there is a notable increase in growth opportunities projected for the forthcoming years. This ...

Dr. Yolanda Ragland practices podiatric medicine. A podiatric reconstruction forefoot surgeon, Dr. Ragland maintains a Park Avenue office in New York City and one in the DMV, downtown Silver Spring ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Centric Medical, a division of Life Spine ...

Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Foot and Ankle Devices Market Size, Share and COVID-19 Impact Analysis 2023-2029 MedCore - Includes: Primary Ankle Replacement, Total Ankle Fusion ...

As the global economy recovers in 2021 and the supply of the industrial chain improves, the Hammertoe Correction System market will undergo major changes. According to the latest research, the market ...

Arthrosurface Inc., (www.arthrosurface.com), a developer of less-invasive joint restoration systems, performed its first hammertoe correction surgeries in February using the new, sterile and ...

Georgia medtech startup Cartiva just closed out an $8.5 million Series D, which will fund the company through PMA approval for its synthetic cartilage implant meant for those with osteoarthritis. It ...